Isabelle Matte

1.5k total citations
22 papers, 1.2k citations indexed

About

Isabelle Matte is a scholar working on Immunology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Isabelle Matte has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Molecular Biology and 8 papers in Reproductive Medicine. Recurrent topics in Isabelle Matte's work include Ovarian cancer diagnosis and treatment (8 papers), Galectins and Cancer Biology (7 papers) and Cell death mechanisms and regulation (6 papers). Isabelle Matte is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Galectins and Cancer Biology (7 papers) and Cell death mechanisms and regulation (6 papers). Isabelle Matte collaborates with scholars based in Canada. Isabelle Matte's co-authors include Alain Piché, Claudine Rancourt, Denis Lane, Claude Laplante, Perrine Garde‐Granger, Marianne Boivin, Paul Bessette, Maxime Pinard, Martine Migneault and Alex Carignan and has published in prestigious journals such as Oncogene, Infection and Immunity and British Journal of Cancer.

In The Last Decade

Isabelle Matte

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Matte Canada 20 514 424 403 365 200 22 1.2k
Denis Lane Canada 20 455 0.9× 359 0.8× 391 1.0× 302 0.8× 175 0.9× 26 1.1k
Mark G. Cadungog United States 12 540 1.1× 629 1.5× 524 1.3× 243 0.7× 148 0.7× 17 1.3k
Anniina Färkkilä Finland 21 929 1.8× 648 1.5× 153 0.4× 499 1.4× 265 1.3× 51 1.7k
Jung‐Joo Choi South Korea 24 830 1.6× 316 0.7× 386 1.0× 180 0.5× 508 2.5× 41 1.5k
Julian A. Gingold United States 17 702 1.4× 244 0.6× 173 0.4× 258 0.7× 293 1.5× 60 1.3k
Rosalía I. Cordo Russo Argentina 14 432 0.8× 203 0.5× 547 1.4× 138 0.4× 154 0.8× 27 1.1k
Johanne I. Weberpals Canada 20 687 1.3× 619 1.5× 101 0.3× 378 1.0× 289 1.4× 56 1.3k
Vinod Vathipadiekal United States 16 709 1.4× 286 0.7× 130 0.3× 389 1.1× 301 1.5× 23 1.2k
Rong‐Miao Zhou China 19 459 0.9× 294 0.7× 147 0.4× 178 0.5× 231 1.2× 61 868
Zara Zelenko United States 15 436 0.8× 136 0.3× 378 0.9× 326 0.9× 226 1.1× 16 1.1k

Countries citing papers authored by Isabelle Matte

Since Specialization
Citations

This map shows the geographic impact of Isabelle Matte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Matte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Matte more than expected).

Fields of papers citing papers by Isabelle Matte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Matte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Matte. The network helps show where Isabelle Matte may publish in the future.

Co-authorship network of co-authors of Isabelle Matte

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Matte. A scholar is included among the top collaborators of Isabelle Matte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Matte. Isabelle Matte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matte, Isabelle, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2019). Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway. BMC Cancer. 19(1). 406–406. 30 indexed citations
2.
Matte, Isabelle, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2019). Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer.. PubMed. 9(1). 160–170. 18 indexed citations
3.
Lane, Denis, Isabelle Matte, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2018). Ascites IL-10 Promotes Ovarian Cancer Cell Migration. Cancer Microenvironment. 11(2-3). 115–124. 26 indexed citations
4.
Matte, Isabelle, Perrine Garde‐Granger, Claude Laplante, et al.. (2016). Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Clinical & Experimental Metastasis. 33(8). 839–852. 34 indexed citations
5.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2016). CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Molecular Cancer. 15(1). 58–58. 57 indexed citations
6.
Lane, Denis, Isabelle Matte, Perrine Garde‐Granger, et al.. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer. 15(1). 492–492. 62 indexed citations
7.
Matte, Isabelle, et al.. (2015). MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.. PubMed. 5(1). 219–30. 30 indexed citations
8.
Matte, Isabelle, Denis Lane, Dimcho Bachvarov, Claudine Rancourt, & Alain Piché. (2014). Role of malignant ascites on human mesothelial cells and their gene expression profiles. BMC Cancer. 14(1). 288–288. 31 indexed citations
9.
Matte, Isabelle, Denis Lane, Marianne Boivin, Claudine Rancourt, & Alain Piché. (2014). MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression. BMC Cancer. 14(1). 234–234. 31 indexed citations
10.
Matte, Isabelle, et al.. (2014). Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail. International Journal of Oncology. 46(1). 91–98. 16 indexed citations
11.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2013). Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis. Journal of Ovarian Research. 6(1). 82–82. 33 indexed citations
12.
Matte, Isabelle, et al.. (2012). Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis. Molecular Cancer. 11(1). 84–84. 42 indexed citations
13.
Lane, Denis, Isabelle Matte, Claudine Rancourt, & Alain Piché. (2012). Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. Journal of Ovarian Research. 5(1). 34–34. 37 indexed citations
14.
Matte, Isabelle, Denis Lane, Claude Laplante, Claudine Rancourt, & Alain Piché. (2012). Profiling of cytokines in human epithelial ovarian cancer ascites.. PubMed. 2(5). 566–80. 150 indexed citations
15.
Thériault, Catherine, Maxime Pinard, Martine Migneault, et al.. (2011). MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecologic Oncology. 121(3). 434–443. 144 indexed citations
16.
Lane, Denis, Isabelle Matte, Claudine Rancourt, & Alain Piché. (2011). Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer. 11(1). 210–210. 148 indexed citations
17.
Pinard, Maxime, Caroline Thériault, Isabelle Matte, et al.. (2011). Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells. British Journal of Cancer. 104(6). 989–999. 91 indexed citations
18.
Lane, Denis, Isabelle Matte, Claudine Rancourt, & Alain Piché. (2010). The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. Journal of Ovarian Research. 3(1). 1–1. 44 indexed citations
19.
Lane, David P., et al.. (2010). The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells. Oncogene. 29(40). 5523–5536. 50 indexed citations
20.
Matte, Isabelle, et al.. (2009). Antiapoptotic Proteins Bcl-2 and Bcl-X L Inhibit Clostridium difficile Toxin A-Induced Cell Death in Human Epithelial Cells. Infection and Immunity. 77(12). 5400–5410. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Lane Breakdown of academic impact, for papers by Mark G. Cadungog Breakdown of academic impact, for papers by Anniina Färkkilä Breakdown of academic impact, for papers by Jung‐Joo Choi Breakdown of academic impact, for papers by Julian A. Gingold Breakdown of academic impact, for papers by Rosalía I. Cordo Russo Breakdown of academic impact, for papers by Johanne I. Weberpals Breakdown of academic impact, for papers by Vinod Vathipadiekal Breakdown of academic impact, for papers by Rong‐Miao Zhou Breakdown of academic impact, for papers by Zara Zelenko
Rankless by CCL
2026